Home

Why Choose Medcrave Mission & Vision Partners & Supporters News & Press Release

Journals eBooks Videos Reprints

Magazines Editors-in-Chief FAQs Contact Us ☰

Prevalence and manifestations of HER2-low breast cancer in patients with unresectable and/or metastatic disease progressing on anticancer therapy: a retrospective study in the GCC region

: Journal of Cancer Prevention & Current Research
: Salha BJ Al Bader,¹Abdullah Altwairgi,² Abdulwahab Altourah,³ Aref Chehal,⁴ Aydah AlAwadhi,⁴ Diaeddine Trad,⁵ Fathi Azribi,⁶ Mishari Alzahrani,⁷ Muhammad Farooq,⁸ Sharif Kullab,⁹ Syed Hammad Tirmazy,⁸ Mai Behairy,¹⁰ Amgad Kamal,¹⁰ Shereef Elsamany¹¹

PDF Full Text

Keywords

breast neoplasms, neoplasm metastasis, receptor, erbB-2, trastuzumab deruxtecan

© 2014-2026 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at www.medcrave.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera | Terms and Conditions | Privacy Policy

Testimonials